SUMMARYAtropine, the classic muscarinic receptor antagonist, inhibits ion currents mediated by neuronal nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes. At the holding potential of Ϫ80 mV, 1 M atropine inhibits 1 mM acetylcholineinduced inward currents mediated by rat ␣22, ␣24, ␣32, ␣34, ␣42, ␣44, and ␣7 nicotinic receptors by 12-56%. Inward currents induced with a low agonist concentration are equally inhibited (␣32, ␣34), less inhibited (␣24, ␣7), or potentiated (␣42, ␣44) by 1 M atropine. Effects on the more sensitive ␣44 nicotinic receptors were investigated in detail by systematic variation of acetylcholine and atropine concentrations and of membrane potential. At high agonist concentration, atropine inhibits ␣44 nicotinic receptor-mediated ion current in a noncompetitive, voltage-dependent way with IC 50 values of 655 nM at Ϫ80 mV and of 4.5 M at Ϫ40 mV. At low agonist concentration, 1 M atropine potentiates ␣44 nicotinic receptor-mediated ion current. This potentiating effect is surmounted by high concentrations of acetylcholine, indicating a competitive interaction of atropine with the nicotinic receptor, and potentiation is also reversed at high atropine concentrations. Steady state effects of acetylcholine and atropine are accounted for by a model for combined receptor occupation and channel block, in which atropine acts on two distinct sites. The first site is associated with noncompetitive ion channel block. The second site is associated with competitive potentiation, which appears to occur when the agonist recognition sites of the receptor are occupied by acetylcholine and atropine. The apparent affinity of atropine for the agonist recognition sites of the ␣44 nicotinic acetylcholine receptor is estimated to be 29.9 M.The neurotransmitter ACh signals through two distinct types of receptors: nAChRs and mAChRs. These two classes of receptors for ACh were already distinguished pharmacologically by Sir Henry Dale in 1914 (1) on the basis of the resemblance of ACh effects with those of naturally occurring plant alkaloids. mAChRs are activated selectively by muscarine and blocked by atropine, and nAChRs are activated selectively by nicotine and blocked by curare (2, 3). This classification found support from biochemical and electrophysiological data, which showed that nicotinic and muscarinic receptors are functionally distinct entities. Molecular cloning has further demonstrated that the primary structure of nicotinic and muscarinic receptor proteins falls into two different gene families, the ligand-gated ion channels and G protein-coupled receptors, respectively (4 -6).Atropine is still widely used to selectively antagonize mAChRs. mAChRs are sensitive to atropine, with IC 50 values in the nanomolar concentration range (see Ref. 7). At these concentrations, atropine is believed to have few or no side effects on nAChRs because very high (near-millimolar) concentrations of atropine are required to cause any degree of inhibition of the effects of ACh at end-plate-type ...